Dr. Eric Jonasch of the M.D. Anderson Cancer Center in Houston, Texas, provides an update on the progress of the clinical trial for sunitinib (Sutent) for VHL, with special focus on kidney tumors.
This presentation was given at the VHL Family Alliance Regional Meeting in Houston in November 2007. As of this writing (July 2009) this trial is still open to new participants.
